This result may be explained by the small sample size, which is unlikely given that negative findings were also observed in a larger (n = 648) cohort of NAFLD patients [36], or by our observation that circulating IL-2 levels do not reflect local IL-2 expression, and presumably concentration, within the liver. This evidence concerns the gene IL2 and metabolic dysfunction-associated steatotic liver disease.